Literature DB >> 1435620

Differential effects of metal ions on type A and type B monoamine oxidase activities in rat brain and liver mitochondria.

T K Leung1, L Lim, J C Lai.   

Abstract

To investigate the hypothesis that neurotoxic metals can exert their toxicity through the direct inhibition of monoamine oxidases (MAOs), the effects of several neurotoxic metal ions on type A (MAO-A) and type B (MAO-B) monoamine oxidase activities in rat forebrain nonsynaptic mitochondria and rat liver mitochondria were studied. At pathophysiological levels (10-100 microM), Cu2+ and Cd2+ are good inhibitors of brain mitochondrial MAO-A and, to a lesser extent, liver mitochondrial MAO-A. The inhibition of MAO-B activities in brain and liver mitochondria by Cu2+ and Cd2+ is only detected at the higher end of the concentration range (i.e., 50-100 microM). At the pathophysiological level of 0.5 mM, Al3+ only inhibits brain mitochondrial MAO-A but at the higher level of 2.5 mM, it inhibits both forms of MAO in brain as well as liver mitochondria. Even at toxic levels (e.g., 5 mM), neither Mn2+ nor Li+ inhibits the activities of MAO-A and MAO-B in brain and liver mitochondria. Our results are consistent with the hypothesis that some neurotoxic metals can exert their toxicity through the direct inhibition of the isoforms of MAO. Our data also suggest that the selective inhibition of brain MAO-A by Cu2+ and Cd2+ may assume pathophysiological importance in the neurotoxicity of copper and cadmium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1435620     DOI: 10.1007/bf01000159

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  21 in total

1.  The primary structure of bovine monoamine oxidase type A. Comparison with peptide sequences of bovine monoamine oxidase type B and other flavoenzymes.

Authors:  J F Powell; Y P Hsu; W Weyler; S A Chen; J Salach; K Andrikopoulos; J Mallet; X O Breakefield
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

2.  cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties.

Authors:  A W Bach; N C Lan; D L Johnson; C W Abell; M E Bembenek; S W Kwan; P H Seeburg; J C Shih
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

3.  Preparation of synaptic and nonsynaptic mitochondria from mammalian brain.

Authors:  J C Lai; J B Clark
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

4.  Some puzzling pharmacological effects of monoamine oxidase inhibitors.

Authors:  J Knoll; K Magyar
Journal:  Adv Biochem Psychopharmacol       Date:  1972

5.  Tissue distribution of human monoamine oxidase A and B mRNA.

Authors:  J Grimsby; N C Lan; R Neve; K Chen; J C Shih
Journal:  J Neurochem       Date:  1990-10       Impact factor: 5.372

6.  The activities of the A and B forms of monoamine oxidase in liver, hypothalamus and cerebral cortex of the female rat: effects of administration of ethinyloestradiol and the progestogens norethisterone acetate and d-norgestrel.

Authors:  T K Leung; J C Lai; W Marr; L Lim
Journal:  Biochem Soc Trans       Date:  1980-10       Impact factor: 5.407

7.  Comparison of the inhibitory effects of mercuric chloride on cytosolic and mitochondrial hexokinase activities in rat brain, kidney and spleen.

Authors:  J C Lai; H N Barrow
Journal:  Comp Biochem Physiol C       Date:  1984

8.  Immunological uniqueness of human monoamine oxidases A and B: new evidence from studies with monoclonal antibodies to human monoamine oxidase A.

Authors:  L M Kochersperger; A Waguespack; J C Patterson; C C Hsieh; W Weyler; J I Salach; R M Denney
Journal:  J Neurosci       Date:  1985-11       Impact factor: 6.167

9.  Inhibition of brain glycolysis by aluminum.

Authors:  J C Lai; J P Blass
Journal:  J Neurochem       Date:  1984-02       Impact factor: 5.372

10.  Effects of repeated lithium administration on the subcellular distribution of 5-hydroxytryptamine in rat brain.

Authors:  C K Atterwill; A F Tordoff
Journal:  Br J Pharmacol       Date:  1982-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.